Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Oras A Alabas

6PUBLICATIONS

18CO-AUTHORS

Immunogenetics (incl. genetic immunology)Gene and molecular therapyRegenerative medicine (incl. stem cells)Rheumatology and arthritis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|May 29, 2025

Drug survival of IL-23 and IL-17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study.

Leila Motedayen Aval, Zenas Z N Yiu, Oras A Alabas

|Jan 10, 2025

Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu

|Jan 03, 2024

A sprinkle of methotrexate to go with biologics: a safe recipe?

Oras A Alabas, Zenas Z N Yiu

|Dec 05, 2023

The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu

|Nov 12, 2023

Characteristics of 'super responders' and 'super nonresponders' to first biologic monotherapy for psoriasis: a nested case-control study.

Kayleigh J Mason, Oras A Alabas, Nick Dand

|Dec 11, 2021

Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis.

Sayam Dubash, Oras A Alabas, Xabier Michelena

Pageof 1

Frequent Collaborators

5 joint publications

Zenas Z N Yiu

3 joint publications

Richard B Warren

3 joint publications

Kayleigh J Mason

2 joint publications

Christopher E M Griffiths

2 joint publications

Catherine H Smith

2 joint publications

Nick Dand

1 joint publications

Xabier Michelena

1 joint publications

Leticia Garcia-Montoya

1 joint publications

Leila Motedayen Aval

1 joint publications

Philip S Helliwell

Frequent Collaborators

5 joint publications

Zenas Z N Yiu

3 joint publications

Richard B Warren

3 joint publications

Kayleigh J Mason

2 joint publications

Christopher E M Griffiths

Top Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on : Nov 08, 2015

See more related videos

Top Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on : Nov 08, 2015

See more related videos